Alto Neuroscience Report issue

For profit Phase 2 Phase 4
Founded: Los Altos CA United States (2019)
Status: No NME R&D (2019)

Organization Overview

First Clinical Trial
2020
NCT04388202
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Alto Neuroscience